Derkjen van Zeben
Derkjen van Zeben publishes mostly in Rheumatology, Hematology and Nephrology, on topics such as Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Spondyloarthritis Studies and Treatments.
- World rank
- #419,789 of 7,710,434 ranked researchers
- Rank in Netherlands
- #10,522 of 107,149
- Works
- 49
- Citations
- 5.1k
- Citations per work
- 104.5
What does Derkjen van Zeben research?
Derkjen van Zeben's work is mostly in Medicine (71%), Immunology and Microbiology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3571.0%
- Medicine3571.0%
- Everything else1326.9%
- Life Sciences12.1%
- 1Rheumatology54% of their works
- 2Hematology8% of their works
- 3Nephrology4% of their works
- 4Rehabilitation3% of their works
- 5Genetics3% of their works
- 6Immunology2% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Autoimmune and Inflammatory Disorders Research
- Gout, Hyperuricemia, Uric Acid
- Musculoskeletal Disorders and Rehabilitation
- Chronic Lymphocytic Leukemia Research
- Hepatitis C virus research
Which keywords describe Derkjen van Zeben's research?
The keywords of their largest research topics: Autoantibodies, Cardiovascular Risk, Inflammation, Biological Therapy, Rheumatoid Arthritis, Antiphospholipid Syndrome, Systemic Lupus Erythematosus and Ankylosing Spondylitis.
- Hepatitis C Virus
- Chronic Lymphocytic Leukemia
- Medical Education
- Hyperuricemia
- Hemophagocytic Lymphohistiocytosis
- Ankylosing Spondylitis
- Antiphospholipid Syndrome
- Biological Therapy
- Cardiovascular Risk
- Autoantibodies
- Inflammation
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Spondyloarthritis
- Juvenile Idiopathic Arthritis
- Uric Acid
- Musculoskeletal Medicine
- Genomic Aberrations
- Treatment
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Autoantibodies562 topics
- Cardiovascular Risk462 topics
- Inflammation462 topics
- Biological Therapy401 topic
- Rheumatoid Arthritis401 topic
- Antiphospholipid Syndrome161 topic
- Systemic Lupus Erythematosus161 topic
- Ankylosing Spondylitis131 topic
- Spondyloarthritis131 topic
- Hemophagocytic Lymphohistiocytosis101 topic
- Juvenile Idiopathic Arthritis101 topic
- Hyperuricemia61 topic
- Uric Acid61 topic
- Medical Education41 topic
- Musculoskeletal Medicine41 topic
- Chronic Lymphocytic Leukemia31 topic
- Genomic Aberrations31 topic
- Hepatitis C Virus31 topic
- Treatment31 topic
Where does Derkjen van Zeben work?
Derkjen van Zeben's main affiliation in the publication record is Sint Franciscus Gasthuis, Netherlands.
How many publications and citations does Derkjen van Zeben have?
OpenAlex counts 49 works and 5,120 citations for Derkjen van Zeben, an h-index of 26, ranking #419,789 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Derkjen van Zeben. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.